Tom Thomas
Principal Investor Newpath Partners
Seminars
Wednesday 2nd December 2026
Audience Discussion: Deal-Making & Acquisition Drivers in the Next Wave of Cell Therapy
4:00 pm
- Evaluating which cell therapy modalities and platforms are attracting investment and acquisition interest
- Assessing competitive positioning as multiple programs advance toward pivotal trials and regulatory submissions
- Understanding investor perspectives on autologous versus allogeneic versus in vivo approaches for long-term market viability
